The RIQAS Maternal Screening Program is a monthly EQA program designed to monitor the performance of screening tests used during the first and second trimester of pregnancy to assess the risk of Down’s Syndrome, Spina Bifida and Trisomy 18. Results are submitted on a monthly basis with sophisticated yet easy to interpret reports provided within 24-48 hours to enable any corrective actions to be taken as soon as possible. 100% human sera mirrors the performance of patient samples.
• Unique combination of parameters in a single serum sample, suitable for both First and Second Trimester screening • Total hCG present at approximately 8000-45000U/L • User friendly reports received within 48 hours of the final submission date • Register up to 5 instruments at no extra cost.
RIQAS is the largest international EQA scheme in the world with over 22,000 participants in more than 100 countries.
RIQAS Key Benefits • High quality samples • Flexible programme options • Accreditation to a number of internationally recognised standards including ILAC G13:2007 (ISO/IEC 17043) and ISO13485 • Unrivalled technical support via our team of RIQAS scientists and experts